Frequency of leukemic initiating cells does not depend on the xenotransplantation model used

Leukemia

Volumn 26, Issue 4, 2012, Pages 858-860

  Vargaftig, J ^a   Taussig, D C ^a,b   Griessinger, E ^a   Anjos Afonso, F ^a   Lister, T A ^b   Cavenagh, J ^b   Oakervee, H ^b   Gribben, J ^b   Bonnet, D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD47 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CELL CULTURE; CANCER MODEL; CANCER PATIENT; HEAD AND NECK CARCINOMA; HUMAN; INNATE IMMUNITY; LETTER; LEUKEMIA CELL; LUNG NON SMALL CELL CANCER; MELANOMA; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD47; DISEASE MODELS, ANIMAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED NOD; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RECEPTORS, INTERLEUKIN-2; TRANSPLANTATION, HETEROLOGOUS;

EID: 84859639717     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.250     Document Type: Letter

References (15)

1. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648. (Pubitemid 24067706)
2. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737. (Pubitemid 27298715)
3. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumor formation by single melanoma cells. Nature 2008; 456: 593-598.
4. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-137.
5. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010; 18: 510-523.
6. Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 2010; 7: 279-282.
7. Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Ridler C, Lillington D et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008; 112: 568-575.
8. Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109-2117.
9. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rãc-deficient mice. J Clin Invest 2011; 121: 384-395.
10. Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G et al. Human acute leukemia cells injected in NOD/LtSz-scid/IL2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid related strains. Int J Cancer 2008; 123: 2222-2227.
11. Pearce DJ, Taussig D, Zibara K, Smith LL, Ridler CM, Preudhomme C et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 2006; 107: 1166-1173. (Pubitemid 43156319)
12. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009; 138: 271-285.
13. Van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 2005; 11: 6520-6527. (Pubitemid 41338990)
14. Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 (-) fraction. Blood 2010; 115: 1976-1984.
15. Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 2010; 24: 1785-1788.